Scientists given research cloning go-ahead (UK)
By BBC News,
BBC News
| 08. 11. 2004
The Human Fertilisation and Embryology Authority granted the licence to experts at the University of Newcastle.
They are investigating new treatments for conditions including diabetes, Parkinson's and Alzheimer's disease.
The controversial decision could open a new era of research by scientists looking for remedies for diseases.
| |
This is an important area of research and a responsible use of technology
Suzi Leather, Human Fertilisation and Embryology Authority Listen to her interview
|
The research will take place at the International Centre for Life in Newcastle, involving experts from the Institute of Human Genetics at Newcastle University, and the Newcastle Fertility Centre.
Scientists there believe this is the first time such a licence has been granted in any European country.
They warn it will be at least five years - if not many more - before patients could receive stem cell treatments based on their work.
But the ProLife Party has said it is considering mounting a legal challenge against the HFEA's decision to allow the research to go ahead.
Support
...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
